tirzepatide in adolescents adolescent obesity trial VisualAbstract: Tirzepatide Superior to Semaglutide Obese Adults Without Diabetes Efficacy and safety of tirzepatide
Description
Weight Loss Efficacy: advantage goes to CagriSema
doi: 10.1046/j.1471-4159.1996.67051982.x
These symptoms are most noticeable during the first 12 weeks of treatment, often referred to as the dose-escalation phase
The treatment assists appetite control, making balanced meals more manageable
